Therapy Areas: AIDS & HIV
Study Finds That Children's Immune Response Protects Against COVID-19
21 September 2020 - - The first study comparing the immune responses of adults and children with COVID-19 has detected key differences that may contribute to understanding why children usually have mi...
Healthvana Launches Patient Platform to Support CDC's COVID-19 Vaccination Playbook
18 September 2020 - - US-based Healthvana, Inc., a patient platform for COVID-19 and HIV test results, has launched a new mobile vaccination record and patient follow-up solution to support the CDC CO...
Experimental Drug Blocks COVID-19 Viral Entry into Lung Cells
18 September 2020 - - An experimental compound prevents the virus that causes COVID-19 from entering human airway cells, a new study finds. The effort was led by researchers at the NYU Grossman School...
Healthvana expands patient platform for COVID-19 test results to include flu and COVID-19 vaccination records and patient follow-up
18 September 2020 - Healthvana Inc, a patient platform for COVID-19 and HIV test results, on Thursday announced the launch of its new mobile vaccination record and patient follow-up solution to suppor...
Excelra collaborates with Standigm
16 September 2020 - Excelra, a global data science and data analytics company, has collaborated with Standigm Inc, a company using artificial intelligence technology for drug discovery and development...
Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial
14 September 2020 - - US-based drugmaker Pfizer Inc. (NYSE: PFE) and Germany-based BioNTech SE (NASDAQ: BNTX) have submitted an amended protocol to the US Food and Drug Administration t...
Related Headlines

Gannex files ASC42 IND with FDA for NASH

Development of COVID-19 Vaccine AZD1222 Expands Into US Phase III Clinical Trial Across All Adult Age Groups

AstraZeneca commences Phase 3 trials of potential COVID-19 vaccine in the US

AIDS Group Warns Not to Cut Corners on Safety and Efficacy of COVID-19 Vax

Healthvana Delivers Over 1m COVID-19 Test Results in Three Months

NantKwest and ImmunityBio Team On Joint Development, Manufacturing, Marketing, and Commercialisation of COVID-19 Vaccine and Related Therapeutics

LabCorp Will Perform Antibody Test at No Charge to Accelerate COVID-19 Blood Plasma Donation

The New England Journal of Medicine Publishes Non-Human Primate Preclinical Viral Challenge Study of an mRNA Vaccine Against COVID-19

IAVI and Wellcome Issue a Global Call to Action: Monoclonal Antibodies for COVID-19 and Other Diseases Could Save Millions of Lives

Terns Pharmaceuticals Names Sundaram as CEO, Vignola as CFO

ViiV Healthcare Wins FDA Nod of Expanded Dovato Indication

Members of The COVID R and D Alliance and Quantum Leap Healthcare Collaborative Enroll First Patients In I-SPY COVID Trial

ImmunityBio Study Shows Positive T Cell and Antibody Immune Responses to its COVID-19 Vaccine Candidate that Targets Both Spike and Nucleocapsid Virus Proteins

Nature Publishes Non-Human Primate Preclinical Viral Challenge Study of Single-shot Ad26 Vaccine that Protects Against SARS-CoV-2

AIDS Organisation AHF Calls for Truly Independent Evaluation of WHO Response to COVID-19